Global Hemodialysis Powder Solution
Market Definition
Hemodialysis powder solutions are concentrates or dialysates, mainly used to remove waste materials from the blood and retain useful components from leaving the blood. It is also used to correct acid-base and electrolyte imbalance during chronic renal failure In hemodialysis, blood is removed from the body and filtered through a man-made membrane called a dialyzer, or artificial kidney, and then the filtered blood is returned to the body. The average person has about 10 to 12 pints of blood; during dialysis only one pint (about two cups) is outside of the body at a time. To perform hemodialysis there needs to be an access created to get the blood from the body to the dialyzer and back to the body. There are three access types for hemodialysis: arteriovenous (AV) fistula, AV graft and central venous catheter. The AV fistula is the vascular access most recommended by the dialysis community.
Some of the biggest players operating in the Hemodialysis Powder Solution Market include Fresenius SE & Co. KGaA, Baxter, and Rockwell Medical, Inc., and other prominent key players
Market Size
- 2016: USD 4,027.2 Million
- 2020: USD 4,623.2 Million
- 2026: USD 5,808.8 Million
CAGR (2025 – 2031)
- 4.67%
- Asia Pacific
- Hospitals
- Others (Home Care)
- A powder B powder
- A liquid B powder
- Rising prevalence of chronic kidney disease (CKD) and renal disorders
- Growing investments in the R&D and medical care
- Rising expenditure on healthcare
- High growth opportunities in the emerging market
- Fresenius SE & Co. KGaA
- Baxter
- Rockwell Medical, Inc.
- 1. Executive Summary
- 1.1 Regional Market Share
- 1.2 Hemodialysis Powder Solution Market: COVID-19 Outbreak
- 2. Research Methodology
- 2.1 Research Objective
- 2.2 Research Approach
- 2.3 Data Sourcing and Methodology
- 2.4 Primary Research
- 2.5 Secondary Research
- 2.6 Market Size Estimation and Data Triangulation
- 3. Market Characteristics
- 3.1 Market Definition
- 3.2 Key Segmentations
- 3.3 Key Developments
- 4. Recent Developments
- 4.1 Overview
- 4.2 Product Lauch
- 4.3 Mergers & Acquisitions Activities
- 4.4 Latest Technological Advancements
- 5. Market Dynamics
- 5.1 Introduction
- 5.2 Growth Drivers
- 5.2.1 Rising prevalence of chronic kidney disease (CKD) and renal disorders
- 5.2.2 Growing investments in the R&D and medical care
- 5.3 Market Opportunities
- 5.3.1 Rising expenditure on healthcare
- 5.3.2 High growth opportunities in the emerging market
- 5.4 Market Restraints
- 5.4.1 Stringent rules & regulations
- 5.4.2 Risk and complications associated with contamination of dialysates
- 5.5 Market Trends
- 5.5.1 Advancements in Technology
- 5.5.2 Remote monitoring to support self-care
- 6. Market Analysis
- 6.1 Porters Five Forces
- 6.1.1 Threat of New Entrants
- 6.1.2 Bargaining Power of Customer
- 6.1.3 Bargaining Power of Suppliers
- 6.1.4 Threat of Substitutes
- 6.1.5 Competitive rivalry
- 6.2 PEST Analysis
- 6.2.1 Political
- 6.2.2 Economic
- 6.2.3 Social
- 6.2.4 Technological
- 7. Global Hemodialysis Powder Solution Market Size
- 7.1 Overview
- 7.2 Regional Market Share
- 7.3 Recent Developments (3 years)
- 8. Global Hemodialysis Powder Solution Market Segmentation by Region
- 8.1 North America Hemodialysis Powder Solution Market
- 8.2 Europe Hemodialysis Powder Solution Market
- 8.3 China Hemodialysis Powder Solution Market
- 8.4 Japan Hemodialysis Powder Solution Market
- 8.5 India Hemodialysis Powder Solution Market
- 8.6 South America Hemodialysis Powder Solution Market
- 8.7 Middle-East & Africa Hemodialysis Powder Solution Market
- 9. Market Snippet
- 9.1 Overview
- 9.2 Global Hemodialysis Powder Solution Market: By Application (Value)
- 9.2.1 By Application: Hospital
- 9.2.2 By Application: Laboratory
- 9.2.3 By Application: Others
- 9.2.4 Market Share, By Application (2019 –2026)
- 9.3 Global Hemodialysis Powder Solution Market: By Type
- 9.3.1 By Type: A liquid B liquid
- 9.3.2 By Type: A liquid B powder
- 9.3.3 By Type: A powder B powder
- 9.3.4 Market Share, By Type (2019 –2026)
- 9.4 Key Insights and Recent Developments
- 10. Competitive Landscape
- 10.1 Overview
- 10.2 Market Share Analysis
- 11. Company Profiles
- 11.1 Fresenius SE & Co. KGaA
- 11.1.1.1 Company Overview
- 11.1.1.2 Financial Overview
- 11.1.1.3 Key Product; Analysis
- 11.1.1.4 Company Assessment
- 11.1.1.4.1 Product Portfolio
- 11.1.1.4.2 Key Clients
- 11.1.1.4.3 Market Share
- 11.1.1.4.4 Recent News & Development (Last 3 Yrs.)
- 11.1.1.4.5 Executive Team
- 11.2 Baxter International Inc
- 11.3 Rockwell Medical, Inc
- 11.4 Farmasol
- 11.5 O.M.A.R S.r.l Pharmaceutical Blister Solution
- 11.6 WEGO Health Co., Ltd.
- 11.7 Renacon Pharma Limited
- 12. Appendix
- 13. Consultant Recommendation
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook